Biography
Colleen Seidel is an associate in Weil’s Technology and IP Transactions practice and is based in New York. Colleen participates in the representation of Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Colleene has been part of the teams advising:
- Eli Lilly and Company in its acquisition of certain assets from Organovo Holdings, Inc.
- Everstream Solutions LLC (a portfolio company of InfraBridge Investors and DigitalBridge Group) in its sale of certain network assets to Lakefront Fiber
- Midwest Fiber Holdings LP in its entry into a $285 million stalking horse asset purchase agreement with Bluebird MidWest, LLC, an affiliate of Bluebird Fiber, in connection with its chapter 11 proceedings
Colleen joined Weil as a summer associate in 2022.
Colleen received her J.D. from Harvard Law School where she worked as a student attorney in the Health Law and Policy Clinic. She received her B.A. from Vanderbilt University.